Status:
COMPLETED
Safety and Efficacy of Oral Mega Pulse Methylprednisolone in Severe Therapy Resistant Alopecia Areata
Lead Sponsor:
King Saud University
Collaborating Sponsors:
Saudi Society of Dermatology and Dermatologic surgery
Conditions:
Alopecia Totalis
Alopecia Universalis
Eligibility:
All Genders
5+ years
Phase:
PHASE4
Brief Summary
Systemic Pulse Glucocorticoids have been shown to be effective in widespread Alopecia areata but not the totalis, universalis or ophiasic type. Whether the failure is due to inadequate dosing, inadequ...
Detailed Description
This will be a single-center, prospective, randomized study conducted in King Khalid University Hospital. Patients diagnosed with either Alopecia universalis, Alopecia totalis or Ophiasic alopecia wil...
Eligibility Criteria
Inclusion
- Alopecia Universalis
- Alopecia Totalis
- Ophiasic Alopecia
Exclusion
- diabetes mellitus
- peptic ulcer
- hypertension
- infection
- psychosis
- heart disease
- kidney disease
- endocrine disorders (apart from a subclinical hypothyroidism and autoimmune thyroiditis)
- received systemic or topical treatment within the last 4 weeks before enrollment
- pregnancy
Key Trial Info
Start Date :
January 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2010
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT01167946
Start Date
January 1 2003
End Date
July 1 2010
Last Update
July 22 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
King Khalid University Hospital
Riyadh, Riyadh Region, Saudi Arabia, 11472